<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Donnan, J.R.</style></author><author><style face="normal" font="default" size="100%">Chibrikov, E.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Midodzi, W.K.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes Research and Clinical Practice</style></title><secondary-title><style face="normal" font="default" size="100%">The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85039789313&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>